__NOTOC__
Sandoz Inc. v. Amgen Inc., , was a United States Supreme Court case in which the court held that Section 262(l)(2)(A) of the Biologics Price Competition and Innovation Act of 2009 is not enforceable by injunction under federal law. An applicant may provide notice under Section 262(l)(8)(A) prior to obtaining licensure..
References
External links